Shuttle Pharmaceuticals Holdings (SHPH) Preferred Dividend Payments (2021 - 2022)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Preferred Dividend Payments came in at $368418.0 in Q4 2022, up 1330.31% year-on-year from $25758.0 in Q4 2021, and up 1791.94% quarter-over-quarter from $19473.0 in Q3 2022.
Shuttle Pharmaceuticals Holdings (SHPH) Preferred Dividend Payments (2021 - 2022) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $368418.0 for Q4 2022.
- On a quarterly basis, Preferred Dividend Payments rose 1330.31% year-over-year to $368418.0 in Q4 2022; TTM through Dec 2022 was $439427.0, a N/A change from a year earlier, with the FY2022 full-year figure at $439427.0, up 326.37% from the prior year.
- Preferred Dividend Payments climbed to $368418.0 in Q4 2022 per SHPH's latest filing, from $19473.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $368418.0 in Q4 2022 and bottomed at $19473.0 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.42 Mn | 1.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 368,418.00 |
| Sep 30, 2022 | 19,473.00 |
| Jun 30, 2022 | 25,768.00 |
| Mar 31, 2022 | 25,768.00 |
| Dec 31, 2021 | 25,758.00 |
| Sep 30, 2021 | 25,768.00 |